
John M Ford
Examiner (ID: 4717)
| Most Active Art Unit | 1201 |
| Art Unit(s) | 1202, 1201, 1611, 1205, 1624 |
| Total Applications | 2711 |
| Issued Applications | 2304 |
| Pending Applications | 29 |
| Abandoned Applications | 378 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4240701
[patent_doc_number] => 06166206
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-26
[patent_title] => 'Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments'
[patent_app_type] => 1
[patent_app_number] => 9/506090
[patent_app_country] => US
[patent_app_date] => 2000-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13012
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 457
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/166/06166206.pdf
[firstpage_image] =>[orig_patent_app_number] => 506090
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/506090 | Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments | Feb 16, 2000 | Issued |
Array
(
[id] => 4250728
[patent_doc_number] => 06136974
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-24
[patent_title] => 'Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments'
[patent_app_type] => 1
[patent_app_number] => 9/505857
[patent_app_country] => US
[patent_app_date] => 2000-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13418
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 432
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/136/06136974.pdf
[firstpage_image] =>[orig_patent_app_number] => 505857
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/505857 | Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments | Feb 16, 2000 | Issued |
Array
(
[id] => 1491257
[patent_doc_number] => 06417360
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-09
[patent_title] => 'Heterocyclic sulfonamides'
[patent_app_type] => B1
[patent_app_number] => 09/505548
[patent_app_country] => US
[patent_app_date] => 2000-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4952
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/417/06417360.pdf
[firstpage_image] =>[orig_patent_app_number] => 09505548
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/505548 | Heterocyclic sulfonamides | Feb 16, 2000 | Issued |
Array
(
[id] => 4307036
[patent_doc_number] => 06252069
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-26
[patent_title] => 'Method for the production of 3-isopropyl-1H-2, 1,3-benzothiadiazine-4 (3H)-one-2,2-dioxide'
[patent_app_type] => 1
[patent_app_number] => 9/485768
[patent_app_country] => US
[patent_app_date] => 2000-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3876
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/252/06252069.pdf
[firstpage_image] =>[orig_patent_app_number] => 485768
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/485768 | Method for the production of 3-isopropyl-1H-2, 1,3-benzothiadiazine-4 (3H)-one-2,2-dioxide | Feb 16, 2000 | Issued |
Array
(
[id] => 1111347
[patent_doc_number] => 06806267
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-19
[patent_title] => 'Apoptosis-inducing compounds'
[patent_app_type] => B1
[patent_app_number] => 09/506362
[patent_app_country] => US
[patent_app_date] => 2000-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 26242
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/806/06806267.pdf
[firstpage_image] =>[orig_patent_app_number] => 09506362
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/506362 | Apoptosis-inducing compounds | Feb 15, 2000 | Issued |
Array
(
[id] => 1068911
[patent_doc_number] => 06844437
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-01-18
[patent_title] => 'Process for the production of tert-butyl (E)-(6-[2-[4-(4-flurophenyl)-6-isopropyl-2-[methyl(methylsufonyl)amino]pyrimidin-5-yl]vinyl]4R,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate'
[patent_app_type] => utility
[patent_app_number] => 09/913539
[patent_app_country] => US
[patent_app_date] => 2000-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3097
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/844/06844437.pdf
[firstpage_image] =>[orig_patent_app_number] => 09913539
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/913539 | Process for the production of tert-butyl (E)-(6-[2-[4-(4-flurophenyl)-6-isopropyl-2-[methyl(methylsufonyl)amino]pyrimidin-5-yl]vinyl]4R,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate | Feb 14, 2000 | Issued |
Array
(
[id] => 1504244
[patent_doc_number] => 06465476
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-15
[patent_title] => 'Immuno-modulator exhibiting antimicrobial and anti-mycrobacterial activities, method for producing the same and pharmaceutical preparation'
[patent_app_type] => B1
[patent_app_number] => 09/485779
[patent_app_country] => US
[patent_app_date] => 2000-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6019
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/465/06465476.pdf
[firstpage_image] =>[orig_patent_app_number] => 09485779
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/485779 | Immuno-modulator exhibiting antimicrobial and anti-mycrobacterial activities, method for producing the same and pharmaceutical preparation | Feb 13, 2000 | Issued |
| 09/496762 | Process for the preparation of 6-(perfluoroalkyl) uracil compounds from carbamate compounds | Feb 2, 2000 | Abandoned |
Array
(
[id] => 4361751
[patent_doc_number] => 06191275
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-20
[patent_title] => 'Process for the preparation of 6-(perfluoroalkyl) uracil compounds form urea compounds'
[patent_app_type] => 1
[patent_app_number] => 9/496776
[patent_app_country] => US
[patent_app_date] => 2000-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14750
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 276
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/191/06191275.pdf
[firstpage_image] =>[orig_patent_app_number] => 496776
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/496776 | Process for the preparation of 6-(perfluoroalkyl) uracil compounds form urea compounds | Feb 2, 2000 | Issued |
Array
(
[id] => 4192576
[patent_doc_number] => 06153752
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-28
[patent_title] => 'Process for preparing heterocycles'
[patent_app_type] => 1
[patent_app_number] => 9/494258
[patent_app_country] => US
[patent_app_date] => 2000-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3279
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 319
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/153/06153752.pdf
[firstpage_image] =>[orig_patent_app_number] => 494258
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/494258 | Process for preparing heterocycles | Jan 27, 2000 | Issued |
| 09/488582 | Kinase inhibitors | Jan 20, 2000 | Abandoned |
Array
(
[id] => 4412067
[patent_doc_number] => 06265578
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-24
[patent_title] => 'Pyrimidine-2,4,6-triones'
[patent_app_type] => 1
[patent_app_number] => 9/483858
[patent_app_country] => US
[patent_app_date] => 2000-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5484
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/265/06265578.pdf
[firstpage_image] =>[orig_patent_app_number] => 483858
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/483858 | Pyrimidine-2,4,6-triones | Jan 16, 2000 | Issued |
Array
(
[id] => 7636453
[patent_doc_number] => 06380204
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-30
[patent_title] => 'Atropisomers of 3-heteroaryl-4(3H)-quinazolinones for the treatment of neurodegenerative and CNS-trauma related conditions'
[patent_app_type] => B1
[patent_app_number] => 09/380114
[patent_app_country] => US
[patent_app_date] => 2000-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14968
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/380/06380204.pdf
[firstpage_image] =>[orig_patent_app_number] => 09380114
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/380114 | Atropisomers of 3-heteroaryl-4(3H)-quinazolinones for the treatment of neurodegenerative and CNS-trauma related conditions | Jan 12, 2000 | Issued |
Array
(
[id] => 1495528
[patent_doc_number] => 06403593
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-11
[patent_title] => 'Triazole compounds and the use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/481976
[patent_app_country] => US
[patent_app_date] => 2000-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8851
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 328
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/403/06403593.pdf
[firstpage_image] =>[orig_patent_app_number] => 09481976
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/481976 | Triazole compounds and the use thereof | Jan 12, 2000 | Issued |
Array
(
[id] => 4411658
[patent_doc_number] => 06310202
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-30
[patent_title] => 'Nitric oxide carriers based on polyazamacrocycle complexes'
[patent_app_type] => 1
[patent_app_number] => 9/423363
[patent_app_country] => US
[patent_app_date] => 2000-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2160
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/310/06310202.pdf
[firstpage_image] =>[orig_patent_app_number] => 423363
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/423363 | Nitric oxide carriers based on polyazamacrocycle complexes | Jan 10, 2000 | Issued |
Array
(
[id] => 4353201
[patent_doc_number] => 06291485
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => '4,5-dihydro-[1H]-benz[g]indazole-3-carboxylic acid derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/462413
[patent_app_country] => US
[patent_app_date] => 2000-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15567
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291485.pdf
[firstpage_image] =>[orig_patent_app_number] => 462413
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/462413 | 4,5-dihydro-[1H]-benz[g]indazole-3-carboxylic acid derivatives | Jan 9, 2000 | Issued |
Array
(
[id] => 4330776
[patent_doc_number] => 06313114
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => '3,4-Dihydro-2H-benzo[1,4]oxazinyl-methyl)-[3-(1H-indol-3yl)-alkyl]- amines'
[patent_app_type] => 1
[patent_app_number] => 9/475940
[patent_app_country] => US
[patent_app_date] => 1999-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10844
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/313/06313114.pdf
[firstpage_image] =>[orig_patent_app_number] => 475940
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/475940 | 3,4-Dihydro-2H-benzo[1,4]oxazinyl-methyl)-[3-(1H-indol-3yl)-alkyl]- amines | Dec 29, 1999 | Issued |
Array
(
[id] => 4219359
[patent_doc_number] => 06111100
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-29
[patent_title] => 'Preparation of bis(2-morpholinoethyl) ether'
[patent_app_type] => 1
[patent_app_number] => 9/474906
[patent_app_country] => US
[patent_app_date] => 1999-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4593
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/111/06111100.pdf
[firstpage_image] =>[orig_patent_app_number] => 474906
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/474906 | Preparation of bis(2-morpholinoethyl) ether | Dec 29, 1999 | Issued |
Array
(
[id] => 4370520
[patent_doc_number] => 06274732
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-14
[patent_title] => 'Process for the preparation of 1-[(cyclopent-3-en-1-yl)-methyl]-5-ethyl-6-(3,5-dimethylbenzoyl)-2,4-pyrim idinedione'
[patent_app_type] => 1
[patent_app_number] => 9/472978
[patent_app_country] => US
[patent_app_date] => 1999-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1118
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/274/06274732.pdf
[firstpage_image] =>[orig_patent_app_number] => 472978
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/472978 | Process for the preparation of 1-[(cyclopent-3-en-1-yl)-methyl]-5-ethyl-6-(3,5-dimethylbenzoyl)-2,4-pyrim idinedione | Dec 27, 1999 | Issued |
Array
(
[id] => 1459770
[patent_doc_number] => 06391826
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-21
[patent_title] => 'Optically active uracil compounds'
[patent_app_type] => B1
[patent_app_number] => 09/471245
[patent_app_country] => US
[patent_app_date] => 1999-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7787
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/391/06391826.pdf
[firstpage_image] =>[orig_patent_app_number] => 09471245
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/471245 | Optically active uracil compounds | Dec 22, 1999 | Issued |